Deutsche Bank Downgrades Sanofi (SNY) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Jefferies Downgrades Sanofi (SNY) to Hold
October 29, 2014 8:54 AM EDTJefferies downgraded Sanofi (NYSE: SNY) from Buy to Hold.
For an analyst ratings summary and ratings history on Sanofi click here. For more ratings news on Sanofi click here.
Shares of Sanofi closed at $48.07 yesterday.
... MoreBofA/Merrill Lynch Downgrades Sanofi-Aventis (SNY) to Neutral on CEO Removal
October 29, 2014 8:47 AM EDTBofA/Merrill Lynch downgraded Sanofi-Aventis (NYSE: SNY) from Buy to Neutral with a price target of $48.00 after the announcement that it has unanimously voted to remove Chris Viehbacher from his position as CEO.
Analyst Graham Parry said the news is negative for several... More
Barclays Downgrades Sanofi (SNY) to Equalweight
October 29, 2014 8:35 AM EDTBarclays downgraded Sanofi (NYSE: SNY) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Sanofi click here. For more ratings news on Sanofi click here.
Shares of Sanofi closed at $48.07 yesterday.
... MoreSanofi (SNY) Reports Q3 EPS of EUR1.47
October 28, 2014 6:42 AM EDTSanofi (NYSE: SNY) reported Q3 EPS of EUR1.47, EUR0.01 better than the analyst estimate of EUR1.46. Revenue for the quarter came in at EUR8.78 billion.
On diabetes, the company said, "Third-quarter sales of the Diabetes division reached 1,799 million, an increase of 8.3%. Year-to-date sales of the Diabetes division increased 12.5% to 5,249 million. Lantus® sales increased 8.1% to 1,567 million in the third... More
